Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients

American Journal of Cardiology

Volumn 82, Issue 12, 1998, Pages 1532-1535

  Reicher Reiss, Henrietta ^a   Jonas, Michael ^a   Tanne, David ^a   Mandelzweig, Lori ^a   Goldbourt, Uri ^a   Shotan, Avraham ^a   Boyko, Valentina ^a   Behar, Solomon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; CORONARY RISK; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE;

EID: 0032535698     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00701-2     Document Type: Article

References (19)

1. Adams H, Kassell N, Mazuz H. The patient with transient ischemic attacks. Is this the time for a new therapeutic approach? Stroke 1984 ;15:371-375.
2. Hennerici M, Aulich A, Sandman W, Freud HJ. Incidence of asymptomatic extracranial arterial disease. Stroke 1981;12:750-758.
3. Rappaport E, Remedies P. The high risk patient after recovery from myocardial infarction: recognition and management. J Am Coll Cardiol 1983;1:391-400.
4. Pradaens J, Lesaffre E, Willems JL, De Geest H. Multivariate survival analysis for the assessment of prognostic factors and risk categories after recovery from acute myocardial infarction: the Belgian situation. Am J Epidemiol 1985;122: 805-820.
5. Tanne D, Goldbourt U, Zion M, Reicher-Reiss H, Kaplinsky E, Behar S, and the SPRINT Study Group. Frequency and prognosis of stroke/transient ischemic attack among 4808 survivors of acute myocardial infarction. Stroke 1993;24: 1490-1495.
6. Tanne D, Reicher-Reiss H, Boyko V, Behar S, for the SPRINT Study Group. Stroke risk after anterior wall acute myocardial infarction. Am J Cardiol 1995; 76:825-826.
7. Schlant RC, Forman S, Stamler J, Canner PL. The natural history of coronary heart disease: Prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the Coronary Drug Project. Circulation 1982; 66:401-414.
8. Cupples LA, Ganon DR, Wong ND, Ostfeld AM, Kannel WB. Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: The Framingham study. Am Heart J 1993;125;863-872.
9. Goldbourt U, Behar S, Reicher-Reiss H, Agmon J, Kaplinsky E, Graff E, Kishon Y, Caspi A, Weisbort J, Mandelzweig L, et al, for the Bezafibrate Infarction Prevention Study Group. Rationale and design of a secondary preven-tion trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (The Bezafibrate Infarction Prevention Trial). Am J Cardiol 1993:71:909-915.
10. SAS Institute Inc. SAS Technical report P229. SAS/STAT software: changes and enhancements, release 6.07. Cary, NC:SAS Institute Inc., 1992:433-480.
11. SAS Institute Inc. SAS/STAT User's Guide. Version 6, Fourth edition, Volume 2. Cary, NCSAS Institute Inc. 1989:1027-1070.
12. Caplan RL. Cerebrovascular disease and neurologic manifestations of heart disease. In: Hurst JW, Schlant RC, Rackley CE, Sonnenblick EH, Wenger NK, eds. Hurst's The Heart. 8th ed. New York: McGraw-Hill, Inc. 1994:2148-2153.
13. Loh E, Sutton MSJ, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moye LA, Goldhaber SZ, Pfeffer MA. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997:336:251-257.
14. Reed DM. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol 1990:131:579-588.
15. Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L, for the Multiple Risk Factor Intervention Trial Research Group. Risk factors for death from different types of stroke. Ann Epidemiol 1993:3:493-499.
16. Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of Cerebrovascular disease: The Copenhagen City Heart Study. BMJ 1994;309;11-15.
17. Pullicino PM, Xuereb M, Aquilina J, Piedmonte MR. Stroke following acute myocardial infarction in diabetics. J Intern Med 1992:231:287-293.
18. Tanne D, Gottlieb S, Hod H. Reicher-Reiss H, Boyko V, Behar S, for the Secondary Prevention Israeli Nifedipine Trial (SPRINT) and Israeli Thrombolytic Survey Groups. Incidence and mortality from early stroke associated with acute myocardial infarction in the prethrombolytic and thrombolytic eras. J Am Coll Cardiol 1997:30:1484-1494.
19. Tanne D, Gottlieb S, Caspi A, Hod H, Palant A, Reisin L, Rosenfeld T, Peled B, Marmor A, Balkin J, Boyko V, Behar S, for the Israeli Thrombolytic National Survey Group. Treatment and outcome of patients with acute myocardial infarction and prior Cerebrovascular events in the thrombolytic era. Arch Int Med 1998:158:601-606.